RTX vs TXMD · P/E 36, rev $88.60B vs rev $1.8M
RTX Corporation (RTX) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the RTX and TXMD stock pages for the full models.
Not investment advice.